Hyperion Biosystems has created a suite of diagnostic devices that leverage our expertise in computer vision and physics-based algorithms to deliver exquisite performance at the lowest price.

Designing Diagnostics for the Future

What We Offer

We work with leaders in the point-of-care and at-home testing markets to exponentially improve the sensitivity and specificity of their diagnostic offerings without diverting or disrupting resources.

HALO

®

Identifying false positives, delineating non-specific binding and mitigating assay defects enables higher assay performance without redesign.

Learn More →

Gurney with hospital staff pushing_edited.png

Enabling the detection of hundreds to thousands of targets simultaneously, at single-copy sensitivity levels, in less than three hours using standard laboratory equipment.

Coming Soon →

Client Success

"Companies prosper when the cleverness of innovation meets the timely needs of the customer.”

Eric Whitters

COO, Hycor Biomedical, LLC.

14 Examples of custom solutions delivered in a week or less

10x

Average sensitivity enhancement

10,000

Assays run with our algorithms

Featured Stories

Hyperion Biosystems Introduces Helios: A Rapid Molecular Diagnostic Platform with Unparalleled Multiplexed Detection and Single-Copy Sensitivity

January 26, 2026

Harnessing the unmatched specificity of padlock probe chemistry in combination with isothermal amplification and an optical readout, Helios™ can simultaneously detect hundreds to thousands of targets at single-copy sensitivity levels.

Learn More →

Hyperion Biosystems and Colorcon Enter into Licensing Agreement

May 13, 2025

Hyperion Biosystems and Colorcon today announced a licensing agreement to commercialize and market a jointly-developed, anti-counterfeiting technology for solid oral dosage pharmaceutical and nutraceutical products.

Learn More →